EF Hutton Maintains Buy on Nanoviricides, Lowers Price Target to $5.25
EF Hutton analyst Constantine Davides maintains Nanoviricides (AMEX:NNVC) with a Buy and lowers the price target from $8.5 to $5.25.
Short Volatility Alert: NanoViricides, Inc.
On Thursday, shares of NanoViricides, Inc. (NYSE: NNVC) experienced volatile short activity. After the activity, the stock price went up +48.37% to $3.65.
The overall sentiment for NNVC has been Neutral.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
58 Biggest Movers From Yesterday
Gainers
Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
30 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.
Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.
66 Biggest Movers From Friday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
CDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis: CNBC
The Centers for Disease Control and Prevention is now investigating 180 cases of children who suddenly developed severe hepatitis across 36 states and territories, an increase of 71 cases since the public health agency’s last update earlier this month.
Nanoviricides 10-Q Filed Monday Afternoon Showed Q3 EPS $(0.16) Up From $(0.19) YoY
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.16) per share. This is a 15.79 percent increase over losses of $(0.19) per share from the same period last year.